Figure S1. ESTIMATE Immune scores for the 8 datasets, Related to Figure 4
The Sears TheCheatmapCshowsCtheCsignficantCGO-termsCRq<<w<5CinCtheCnon-directionalCclass4CmiddleCcolumn0CandCtheirC tendencyCtoCbeCaffectedCbyCeitherCdown-regulationCorCup-regulationw The first two columns show the number of genes, in general and present in HMR2 (metabolic), that were rescored or added to the score file. The last two columns show the number of reactions associated to these genes, and the number of these that were not already associated with a gene with a positive score. The myocyte tasks that were used as input to tINIT for the GEM reconstruction process. Details on the 286 genes that were not included in iMyocyte2419 but were present in the models by Bordbar and Wang. Details on the 78 negative genes and the reason why they were included in iMyocyte2419.
Genes

Table S6 -Summary of meta-data for the eight datasets, Related to Figure 4
A summary of the sample characteristics of the datasets used in the meta-analysis. The gene-wise z-scores and p-values from the meta-analysis. Gene-set analysis result table returned from piano. Column 1 gives the gene-set names. Column 2-4 gives the number of total, up-regulated, and down-regulated genes in the gene-sets.
Column 5-9 gives the gene-set FDR-adjusted p-values (median of all GSA methods, as given by the consensus GSA approach).
Table S9 -Gene-set analysis results: GO-terms, Related to Figure 4
See legend for Table S8 . See legend for Table S8 .
Table S11 -Impact of the classifier genes on myocyte metabolic tasks, Related to Figure 5 Details on which metabolic tasks that failed when the specified genes were removed from iMyocyte2419.
Supplemental Experimental Procedures
Culturing of myocytes
Isolated satellite cells were cultured in growth media 1 (HAM/F10 supplied with 20% Fetal Bovine Serum and 1% penicillin/streptomycin) and plated in 6-well plates. Upon 70-80% confluence, the media was changed to differentiation media 1 (DMEM 4.5 g/L glucose supplied with 10% FBS and 1% penicillin/streptomycin) for two-three days, until the myoblasts were completely confluent and had lined up. Hereafter, media was changed to differentiation media 2 (DMEM 4.5 g/L glucose supplied with 2% horse serum and 1% penicillin/streptomycin) thereby initiating fusion into myotubes. Media was changed every second day. Cultures were fully differentiated by day 5 of incubation with differentiation media 2, as determined by visual confirmation of myotube formation (>3 nuclei per myotube in ~70% of the cells). Two hours before harvesting of RNA the media was changed to DMEM 1.0 g/L glucose without any supplements.
RNA-sequencing and data analysis
The RNA samples were sequenced with Illumina HiSeq 2000 and 2500 instruments, generating on average 60 million pair-end reads (2x100bp) per sample. The reads were trimmed from adapter sequences and aligned to the human genome (Ensembl GRCh37.73, DNA primary assembly) using STAR 2.3.1u (Dobin et al., 2013) and the corresponding Ensembl gtf-file. The resulting bam-files were indexed and sorted using Samtools 0.1.18 (Li et al., 2009 Protein-coding genes were defined according to the Ensembl GRCh37.73 gtf-file. When logtransforming the FPKM-values, a value of 1 was added to avoid taking the logarithm of 0. Figure  2A was created using the R packages smoothScatter and corrgram. The scatter plots show log10-transformed FPKM-values.
Reconstructing the myocyte GEM
The "Normal tissue" data was downloaded from the Human Protein Atlas version 12. This file is in the format required by the tINIT algorithm, and was therefore edited to reflect the updated scores based on the RNA-seq data: genes with Level "Not detected" and Reliability "Uncertain" were changed to have Level "Low", if their median FPKM-value in the 6 samples was equal to or above one. Genes that were absent in the HPA file, but that had a median FPKM≥1 were added to the file, with the Level "Low" and Reliability "Uncertain". This gave them the lowest possible positive score in tINIT. The reconstruction was run by the function getINITModel (in the Matlab toolbox RAVEN 1.08, using MOSEK 6.0.0.147), using the updated scores, HMR2 as reference model, and the metabolic tasks defined in Table S3 .
Comparing iMyocyte2419 to other models
The SBML-file containing the Wang muscle model was obtained from Wang et al. (2012) and was parsed using the RAVEN toolbox (Agren et al., 2013) . The 688 genes present in the model were annotated using Entrez identifiers, so these were translated into Ensembl identifiers (750 mappings) using the Bioconductor R package biomaRt (Durinck et al., 2009) . Fifteen genes could not be translated due to being outdated, but when checked manually we were able to add 11 additional Ensembl identifiers, resulting in a total gene number of 761.
The Excel-file containing the Bordbar muscle model was obtained from Bordbar et al. (2011) . The 966 genes in the model were annotated using RefSeq gene identifiers, so these were also translated into Ensembl identifiers (677 mappings) as above. Thirty-five genes could not be mapped, but were checked manually, like above, which added additionally 16 Ensembl identifiers, giving a total gene number of 693.
Meta-analysis
To find relevant datasets the GEO database was searched using the following query: "(homo sapiens[Organism] AND muscle) AND (diabetes OR insulin)". The ArrayExpress was also queried using: "muscle AND (diabetes OR insulin)", and the results were filtered for Homo sapiens. From the identified datasets we selected the ones that contained subjects with T2D or insulin resistance, and that had not been given any stimuli (such as insulin or drug) prior to biopsy sampling, according to the description given in the corresponding publications. Finally, we selected the datasets that were using the Affymetrix microarray platform (the majority of the studies), in order to be able to carry out a consistent analysis workflow. The normalized datasets were used as provided by the databases and log2-transformed when not yet done, with exception for Pihlajamäki, Patti, Gallagher and Chibalin which were analyzed starting from the raw CEL-files using the Bioconductor R package affy and normalized using RMA. Probesets identifiers were then mapped to Ensembl identifiers and gene-wise effect sizes and variances were then calculated for each dataset by pooling the probeset effect-sizes and variances using a random-effects model. The meta-analysis was carried out according to Choi et al. (2003) , and as implemented in the Bioconductor R package GeneMeta, using a random-effects model, yielding one z-score for each gene.
Gene-set analyses
The pathway analysis was performed by piano (using the following methods: mean, PAGE, Wilcoxon, GSEA, Maxmean, Reporter, Tail-strength) with the subsystems of iMyocyte2419 as gene-sets and the meta-analysis z-scores as gene-level statistics. Gene-level p-values, as required input for the Reporter and Tail-strength methods, were calculated from the z-scores. The GO-term analysis was performed as above using the methods: mean, PAGE, GSEA, Maxmean, Reporter, Tail-strength. The R-package biomaRt was used to acquire the GO-term gene-sets and only gene-sets with 10-500 genes were considered. Reporter metabolite analysis was performed as above using the methods: mean, PAGE, Wilcoxon, GSEA, Maxmean, Reporter, Tail-strength.
Random forest classification
The significant genes (p<1e-5) associated with the reporter metabolites in Figure 5A were selected for sample classification. Sample classification was then carried out separately on each of the six datasets in the meta-analysis. For this, the probeset identifiers for each dataset were mapped to the Ensembl identifiers in the gene list, using biomaRt. The normalized expression values for these probesets (27 for "HG-U133 plus2" arrays, and 12 for "Hu6800" arrays) in each sample were then used as predictors in a random forest model using the R-package randomForest. This was done by leave-one-out cross-validation, so that the disease state of each sample was predicted using a random forest model based on gene expression data from the remaining samples. A ROC-curve and AUC-value could then be calculated. Due to the randomness of the model, this approach was repeated 100 times to get a distribution of AUCvalues in order to have a more solid estimate of the AUC and its variance. It should be noted that new random forest models were generated for each classification run since the goal was not to find a universal classifier but to investigate the classifying power of the selected genes. AUC-values were also calculated for models based on a list of random probesets or random probesets linked to metabolic genes, repeated 100 times (using the same number of probesets as the original classification). The original AUC scores, for each dataset, could then be compared to those originating from random probeset lists. The ROC-curves displayed in Figure 5C are representative of the median AUC-scores displayed in Figure 5D .
Impact of the classifier genes on myocyte metabolic tasks
The impact of the 12 selected genes on the myocyte function was tested separately for each gene by removing its associated reactions from iMyocyte2419 and thereon testing if the reduced GEM could perform all of the metabolic tasks defined in Table S3 , using the RAVEN toolbox.
Code and scripts
A collection of code, files and scripts used for this work is available at www.metabolicatlas.org.
Supplemental Results
Transcription analysis reveals a higher activity of lipid and energy metabolism in female myocytes
We identified 35 differentially expressed genes in in vitro myocytes (q<0.05) between the male and female subjects, after adjusting for multiple testing (Table S1 ). Out of these, 16 genes were located on the sex chromosomes, including the 5 gender-specific transcript biomarkers RPS4Y1, EIF1AY, DDX3Y, KDM5D and XIST (Staedtler et al., 2013) . Two genes coding for proteins involved in the electron transport chain, NDUFA4L2 and COX7A1, were up-regulated in the female samples (q<0.04). Furthermore, the two receptors CD36 and GPR116, both implicated in the development of insulin resistance (Glatz et al., 2013; Nie et al., 2012) , were also found upregulated in the female samples (q<0.02). CD36 (encoding fatty acid translocase) has multiple known ligands, including lipoproteins (Calvo et al., 1998) , and is involved in long-chain fatty acid uptake in several cells, including skeletal myocytes (Silverstein and Febbraio, 2009 ). Relatively little is known about GPR116 and its ligand is still unidentified, however, the similar proteins GPR43 and GPR120 bind free fatty acids (Oh et al., 2010) . Selective deletion of GPR116 in adipose tissue of mice has been reported to lead to increased levels of circulating triacylglycerol and increased gluconeogenesis and lipogenesis in liver (Nie et al., 2012) , suggesting an involvement in lipid and energy metabolism. The myokine interleukin 6 (IL6), which has been shown to increase the activity of AMPK and enhance glucose uptake in human myocytes (Carey et al., 2006; Kelly et al., 2009; Scheele et al., 2012) , was also up-regulated in the female samples (q<0.03). Taken together, this indicates a more active lipid and energy metabolism in female skeletal muscle, which is in line with previous studies reporting higher basal concentration and exercise-induced net decrease of intramyocellular triacylglycerol (Roepstorff et al., 2006a) as well an increased fatty acid oxidation (Liu et al., 2010; Roepstorff et al., 2006b ) in females.
